Author/Authors :
Al-Mustafa, Mahmoud M. Jordan University Hospital - Department of Anesthesia and Intensive Care, Jordan , Abu-Halaweh, Sami A. Jordan University Hospital - Department of Anesthesia and Intensive Care, Jordan , Aloweidi, AbdelKarim S. Jordan University Hospital - Department of Anesthesia and Intensive Care, Jordan , Murshidi, Mujalli M. Jordan University Hospital - Urology Unit - Department of Special Surgery, Jordan , Ammari, Bassam A. Jordan University Hospital - Urology Unit - Department of Special Surgery, Jordan , Awwad, Ziad M. Jordan University Hospital - Urology Unit - Department of Special Surgery, Jordan , Al-Edwan, Ghazi M. Jordan University Hospital - Urology Unit - Department of Special Surgery, Jordan , Ramsay, Micheal A. Baylor University - Medical Center - Department of Anesthesiology Pain Management, USA
Abstract :
Objectives: To determine the effect of adding dexmedetomidine to bupivacaine for neuraxial anesthesia. Methods: Sixty-six patients were studied between April and May 2008 in the University of Jordan, Amman Jordan. They were randomly assigned into 3 groups, each receiving spinal bupivacaine 12.5mg combined with normal saline (group N) Dexmedetomidine 5μg (group D5), or dexmedetomidine 10μg (group D10). The onset times to reach T10 sensory and Bromage 3 motor block, and the regression times to reach S1 sensory level and Bromage 0 motor scale, were recorded. Results: The mean time of sensory block to reach the T10 dermatome was 4.7±2.0 minutes in D10 group, 6.3±2.7 minutes in D5, and 9.5±3.0 minutes in group N. The mean time to reach Bromage 3 scale was 10.4±3.4 minutes in group D10, 13.0±3.4 minutes in D5, and 18.0±3.3 minutes in group N. The regression time to reach S1 dermatome was 338.9±44.8 minutes in group D10, 277.1±23.2 minutes in D5, and 165.5±32.9 minutes in group N. The regression to Bromage 0 was 302.9±36.7 minutes in D10, 246.4±25.7 minutes in D5, and 140.1±32.3 minutes in group N. Onset and regression of sensory and motor block were highlysignificant (N vesus D5, N versus D10, and D5 versus D10, p 0.001). Conclusion: Dexmedetomidine has a dose dependant effect on the onset and regression of sensory and motor block when used as an adjuvant to bupivacaine in spinal anesthesia.
